Figure 3
Regression of malignancy in a patient with HD. CT scans (A,B) and PET scans (C,D) from patient 2517 (dose level 3.0 mg/kg) showing right hilar adenopathy before (A,C) and 2 months after (B,D) ipilimumab infusion.
Regression of malignancy in a patient with HD. CT scans (A,B) and PET scans (C,D) from patient 2517 (dose level 3.0 mg/kg) showing right hilar adenopathy before (A,C) and 2 months after (B,D) ipilimumab infusion.
